Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
29 April 2013 - P2022
Excess risk of invasive pneumococcal disease and pneumonia in adults with chronic medical conditions
Raymond Farkouh, K. Shea, D. Weycker, R. Farkouh*, D. Strutton, J. Edelsberg, S. Pelton (Boston, Brookline, Collegeville, US)
29 April 2013 - P2106
Clinical response and mortality modelling in tigecycline complicated intra-abdominal infection trials
Matteo Bassetti, M. Bassetti*, D. Meyer, J.L. Yan, M. Wible, A. Quintana, P. McGovern (Udine, IT; Groton, Collegeville, US)
29 April 2013 - P2003
The clinical burden of hospitalised all-cause and pneumococcal meningitis and septicaemia in the Lombardia and Puglia regions of Italy, 2007-2009
Angelyn Cheung, S. Gray*, D. Lambrelli, R. Wasiak, C. Veronesi, M. Raluy, S. Munson, S. Buda, G. Icardi (Collegeville, US; London, UK; Ravenna, IT; Genoa, IT)
29 April 2013 - P2011
Prospective population-based surveillance of the burden of Streptococcus pneumoniae in community-acquired pneumonia in older adults, Chrzanów County, Poland, 2011
Angelyn Cheung, R. Harat, J. Fijolek, E.M. Gutterman, M. Pride, J. Pluta, R. Alexander, S. Gray, J. Kozub* (Chrzanów, PL; Princeton Junction, Pearl River, US; Warsaw, PL; Collegeville, US)
28 April 2013 - P1515
Patterns of resistance among Gram-negative pathogens isolated from countries in Africa and the Middle-East – TEST 2005-2012
Doug Biedenbach, S. Bouchillon*, D. Biedenbach, M. Hackel, D. Hoban, H. Leister-Tebbe (Schaumburg, Collegeville, US)
28 April 2013 - eP728
Incidence and Streptococcus pneumoniae serotype distribution associated with reportable meningitis in Norway, 2007-2009
Angelyn Cheung, S. Gray*, D. Lambrelli, D. Eriksson, S. Munson, R. Wasiak, M. Raluy (Collegeville, US; London, UK)
28 April 2013 - P1525
In vitro activity of tigecyline and comparators among pathogens isolated in Europe from patients with complicated intra-abdominal and skin- and soft tissue-infections –TEST Data 2004-2011
Doug Biedenbach, D. Hoban*, S. Bouchillon, R. Badal, M. Hackel, B. Johnson, H. Leister-Tebbe (Schaumburg, Collegeville, US)
28 April 2013 - P1639
In vitro activity of peptide deformylase inhibitor GSK1322322 against Legionella pneumophila serogroup 1
Jacques Dubois, J. Dubois*, M. Dubois, J.-F. Martel, K. Aubart, D. L. Butler (Sherbrooke, CA; Collegeville, US)
28 April 2013 - P1524
Susceptibility among pathogens isolated from complicated skin and soft tissue infections in Europe; TEST program 2004-2011
Doug Biedenbach, D. Biedenbach*, D. Hoban, M. Hackel, R. Badal, S. Bouchillon, J. Johnson, H. Leister-Tebbe (Schaumburg, Collegeville, US)
28 April 2013 - P1528
Comparison of tigecycline activity between Europe and North America against bloodstream isolates of Enterobacteriaceae; TEST Program 2008-2011
Doug Biedenbach, I. Morrissey*, M. Hackel, D. Hoban, S. Bouchillon, J. Johnson, H. Leister-Tebbe (Epalinges, CH; Schaumburg, Collegeville, US)
28 April 2013 - eP742
The burden of hospitalised multi-cause pneumococcal meningitis in the Rhône-Alpes region, France (2005-2010)
Angelyn Cheung, P. Casez, J. Fauconnier, L. Jorgensen, E.M. Gutterman, S. Gray, S. Munson, J. Gaillat* (Pringy, Grenoble, FR; Princeton Junction, Collegeville, US)
28 April 2013 - P1527
Susceptibility of Gram-positive and Gram-negative anaerobic pathogens isolated from patients in Europe with intra-abdominal infections; TEST Program 2011
Doug Biedenbach, D. Biedenbach*, S. Bouchillon, M. Hackel, S. Hawser, D. Hoban, R. Badal, J. Johnson, H. Leister-Tebbe (Schaumburg, US; Epalinges, CH; Collegeville, US)
28 April 2013 - P1532
Trend analysis of tigecycline and comparator agents against bacterial isolates collected in Europe; TEST Program 2004-2011
Doug Biedenbach, M. Hackel*, S. Hawser, D. Hoban, D. Biedenbach, R. Badal, S. Bouchillon, J. Johnson, H. Leister-Tebbe (Schaumburg, US; Epalinges, CH; Collegeville, US)
28 April 2013 - P1523
Antimicrobial activity of tigecycline on selected Gram-positive and Gram-negative isolates from six European countries; a five-year analysis from the TEST Program 2007-2011
Doug Biedenbach, I. Morrissey*, S. Hawser, M. Hackel, C. Zampaloni, D. Hoban, D. Biedenbach, S. Bouchillon, J. Johnson, H. Leister-Tebbe (Epalinges, CH; Schaumburg, US; Collegeville, US)
28 April 2013 - eP736
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults aged 18–49 years, naïve to 23-valent pneumococcal polysaccharide vaccine
Kristina Bryant, K. Bryant*, R. Frenck, A. Gurtman, J. Rubino, J. Treanor, A. Thompson, T.R. Jones, D. Jayawardene, L.M. Baxter, W.C. Gruber, E.A. Emini, D.A. Scott, B. Schmöle-Thoma (Louisville, Cincinnati, Pearl River, Raleigh, Rochester, Collegeville, US; Maidenhead, UK; Berlin, DE)
27 April 2013 - P920
Pharmacokinetics/pharmacodynamics (PK/PD) of peptide deformylase inhibitor GSK1322322 against Staphylococcus aureus in a rat abscess model
Thomas Lewandowski, T. Lewandowski*, J. Hoover, S. Rittenhouse (Collegeville, US)
27 April 2013 - R2578
Activity of tigecycline against multidrug-resistant Gram-positive and Gram-negative pathogens isolated from Germany in 2008-2011
Doug Biedenbach, S. Bouchillon*, M. Hackel, B. Johnson, D. Hoban, H. Leister-Tebbe (Schaumburg, Collegeville, US)
27 April 2013 - R2583
Distribution and molecular characterisation of beta-lactamases in multidrug-resistant Enterobacteriaceae from the TEST study (2005-2011)
Doug Biedenbach, M. Hackel*, D. Hoban, S. Bouchillon, B. Johnson, H. Leister-Tebbe (Schaumburg, Collegeville, US)
27 April 2013 - R2579
Tigecycline-susceptibility observed among Gram-negative pathogens, including carbapenem-resistant isolates, isolated from patients hospitalised in the United Kingdom; TEST Program 2004-2011
Doug Biedenbach, D. Biedenbach*, B. Johnson, M. Hackel, S. Bouchillon, D. Hoban, R. Badal, H. Leister-Tebbe (Schaumburg, Collegeville, US)
27 April 2013 - R2582
In vitro activity of tigecycline and comparator agents among Escherichia coli and Klebsiella spp., including extended-spectrum beta-lactamases (ESBL)-producing isolates from Nordic countries: TEST program 2004-2011
Doug Biedenbach, D. Biedenbach*, I. Morrissey, M. Hackel, D. Hoban, S. Bouchillon, B. Johnson, H. Leister-Tebbe (Schaumburg, US; Epalinges, CH; Collegeville, US)
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.